Visiongain Publishes Medical Imaging Market Report 2020-2030

22 July 2020
Pharma

Visiongain has launched a new report Medical Imaging Market Report 2020-2030: Forecast by Imaging Technology (X-ray, Tomography (Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, Single-Photon Emission Tomography), Ultrasound Imaging (2D Ultrasound Systems, 3D and 4D Ultrasound Systems, Doppler Imaging), Radiographic Imaging, Other Imaging Technologies)), by Type (2D Imaging, 3D/4D Imaging), by Software Type (Standalone Software, Integrated Software), by Application (Cardiology, Dental, Mammography, Neurology, Oncology, Orthopaedic, Obstetrics & Gynaecology, Urology and Nephrology), by End Users (Ambulatory Surgical Centers, Clinics, Diagnostic Centers, Hospitals, and Research & Academic Institutions) and by Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). Including Forecasts by Major Developed Countries and Developing Countries, Plus Profiles of Leading Companies.

Medical imaging are non-invasive techniques that allow doctors to diagnose diseases and injuries without being intrusive. It has become an essential module of the entire health-care continuum, from screening, early diagnosis, and follow-up. Medical imaging procedures are also used by doctors to determine the best treatment options for patients. Medical imaging tests helps doctors to obtain a better view of organs, blood vessels, tissues, bones, locate tumours, blood clots and other blockages. It also guide medical procedures involving placement of catheters, stents, or other devices inside the body.

According to the Medicare Payment Advisory Commission (MedPAC) and the Centers for Medicare and Medicaid Services (CMS), the rise in volume of imaging services per Medicare beneficiary exceeded the growth of all other services physicians provide. The success of medical imaging is not only about technological advances but also the digital revolution which helped to replace films, permitting multi-planar image reconstruction. Advancements in image acquisition, analysis, transfer, and storage have put medical imaging at the forefront of medical diagnosis. Thus, advances in medical imaging will transform medicine for the masses into precision medicine with personalized care.

The Visiongain report analyst commented “Factors such as increasing demand for early-stage diagnosis of chronic disease and rising aging demographics are anticipated to boost the growth of medical imaging market. In addition, increasing investments, funds, and grants by public-private organizations further drives the market growth.”

On the other hand, shortage of helium, high cost of imaging modalities and unfavourable reimbursement scenario in emerging countries may limit market growth.

The report covers a detailed competitive outlook that includes market share and company profiles of key players operating in the global market. Key players profiled in the report include GE Healthcare, Philips Healthcare, Hitachi Medical Corporation, Hologic, Inc., Siemens Healthcare, Samsung Medison, Shimadzu Corporation, Toshiba Medical Systems Corporation, Esaote S.P.A, and Fujifilm Corporation.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Viral Vectors & Plasmid DNA Manufacturing Market Report 2021-2031

Due to increases in the therapies in progress, the dosages provided, & the patient populations targeted, viral vector production capacity has become increasingly reduced in recent years. The condition is aggravated by COVID-19.

03 December 2020

Read

Visiongain Publishes Drugs of Abuse Testing Market Report 2021-2031

Drugs Abuse has risen very significantly in few last year as compared to previous once and expected to continuously rise over the forecast period. The increase in the drugs abuse creates a huge demand for the drugs of abuse testing products.

03 December 2020

Read

Visiongain Publishes Controlled Substance Market Report 2021-2031

Continuous increasing prevalence of chronic pain is increasing demand for controlled substance as treatment for Chronic pain. Due to which increasing prevalence of chronic pain around the world is working as a driver for the controlled substance market.

03 December 2020

Read

Visiongain Publishes Companion Animal Diagnostics Market Report 2021-2031

All regions are facing rapid growth in the companion animal population. Companion animal are at high risk of developing various diseases for which companion animal require timely diagnosis for the identification, detection and treatment for life causing diseases.

03 December 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever